[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336016-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336016-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","anti-cancer-management-of-head-and-neck-cancers-and-oral-microbiomewhat-can-we-clinically-obtain","Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?","","Head and neck squamous cell carcinoma (HNSCC) is marked by substantial genetic heterogeneity and is commonly linked to the oral cavity and oropharynx, with poor outcomes despite multimodal care. This review connects head and neck cancer treatment (radiotherapy, brachytherapy, surgery, immunotherapy, and chemotherapy) with microbiome dynamics. It highlights altered oral microbiome profiles in patients versus healthy individuals, discusses viral and non-viral risk associations such as HPV and Epstein–Barr virus, and considers microbiome-targeted biomarkers. It also evaluates emerging supportive strategies including preoperative immunonutrition and probiotics.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/anti-cancer-management-of-head-and-neck-cancers-and-oral-microbiomewhat-can-we-clinically-obtain/336016/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/anti-cancer-management-of-head-and-neck-cancers-and-oral-microbiomewhat-can-we-clinically-obtain/336016.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes head and neck squamous cell carcinoma (HNSCC) difficult to manage?","Question",{"text":63,"@type":64},"HNSCC shows significant genetic heterogeneity and has a low 5-year survival rate. Major contributing factors include HPV (notably type 16), Epstein–Barr virus, tobacco, alcohol use, and poor oral hygiene.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the oral microbiome relate to head and neck cancers?",{"text":68,"@type":64},"Differences in oral microbiome profiles have been reported between healthy individuals and patients with head and neck cancers. Certain oral microbes are discussed in the context of altered risk and potential biomarker value.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer treatments are reviewed in relation to the microbiome?",{"text":72,"@type":64},"The review examines reciprocal effects of treatment and microbiome across radiotherapy, brachytherapy, surgery, immunotherapy, and chemotherapy. It links these modalities to possible microbiome-dependent outcomes and side effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336016,1790829572,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","TYPE Review  \nPUBLISHED 28 February 2024 DOI 10.3389/fcimb.2024.1329057  \nOPEN ACCESS  \nEDITED BY  \nJames Butcher,  \nUniversity of Ottawa, Canada  \nREVIEWED BY Zhengrui Li,  \nShanghai Jiao Tong University, China Stefano Monti,  \nBoston University, United States Mohammed Muzamil Khan,  \nBU Chobanian and Avedisian School of Medicine, United States, in collaboration with reviewer SM  \n*CORRESPONDENCE  \nKarolina Kaz´mierczak-Siedlecka  \n karolina. kazmierczak-siedlecka@ [gumed.edu.pl](gumed.edu.pl)  \nLeszek Kalinowski  \n [leszek.kalinowski@gumed.edu.pl](leszek.kalinowski@gumed.edu.pl)  \nRECEIVED 03 November 2023  \nACCEPTED 14 February 2024  \nPUBLISHED 28 February 2024  \nCITATION  \nMakarewicz J, Kaz´ mierczak-Siedlecka K, Sobocki BK, Dobrucki IT, Kalinowski L and Stachowska E (2024) Anti-cancer  \nmanagement of head and neck cancers and oral microbiome—what can we clinically obtain?.  \nFront. Cell. Infect. Microbiol. 14:1329057 .  \ndoi: 10.3389/fcimb.2024.1329057  \nCOPYRIGHT  \n© 2024 Makarewicz, Kaz´mierczak-Siedlecka, Sobocki, Dobrucki, Kalinowski and Stachowska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nAnti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?  \nJakub Makarewicz 1, Karolina Ka´zmierczak-Siedlecka 2*, Bartosz Kamil Sobocki 3, Iwona T. Dobrucki 4,5,6, Leszek Kalinowski 2,7* and Ewa Stachowska 8  \n1Scientiﬁc Circle of Studies Regarding Personalized Medicine Associated with Department of Medical Laboratory Diagnostics, Medical University of Gdansk, Gdansk, Poland, 2 Department of Medical Laboratory Diagnostics—Fahrenheit Biobank [BBMRI.pl](BBMRI.pl), Medical University of Gdansk, Gdansk, Poland, 3 Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland,  \n4 Department of Bioengineering, University of Illinois at Urbana—Champaign, Urbana, IL, United States, 5 Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana—Champaign, Urbana, IL, United States, 6 Department of Biomedical and Translational Sciences, Carle Illinois College of Medicine, University of Illinois at Urbana—Champaign, Urbana, IL, United States, 7 BioTechMed Centre, Department of Mechanics of Materials and Structures, Gdansk University of Technology, Gdansk, Poland, 8 Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Szczecin, Poland  \nHead and neck squamous cell carcinoma (HNSCC) exhibits signiﬁcant genetic heterogeneity and primarily concerns the oral cavity and oropharynx. These cancers occur more frequently in men with a 5-year survival rate below 50% . Major risk factors include human papilloma virus (HPV) (notably type 16), Epstein–Barr virus, tobacco, alcohol, and poor oral hygiene with approximately 4. 5% of global cancers linked to HPV. Notably, differences in the microbiome between healthy individuals and patients with head and neck cancers (HNCs) have been identiﬁed. Recent studies highlight the signiﬁcance of certain oral microbes in risk assessment and the potential of the microbiome as a biomarker for HNCs. Additionally, role of the microbiome in metastasis has been acknowledged. Treatment for HNCs includes local methods, such as surgery and radiotherapy, and systemic approaches, such as immunotherapy. Numerous side effects accompany these treatments. Emerging research suggests the beneﬁcial role of preoperative immunonutrition and probiotics in patient outcomes, emphasizing the inﬂuence of the microbiome on treatment efﬁcacy. This review explores the reciprocal effects of HNC treatment and the gu","cbCaibMRS9GbiTaD","https://ap.wps.com/l/cbCaibMRS9GbiTaD","pdf",1103577,"English","# Introduction\n## Risk factors and survival context\n## Oral microbiome differences\n# Cancer treatment modalities and microbiome interactions\n## Radiotherapy, brachytherapy, surgery\n## Immunotherapy and chemotherapy\n# Emerging interventions\n## Preoperative immunonutrition and probiotics\n# Conclusion and clinical outlook","[{\"question\":\"What makes head and neck squamous cell carcinoma (HNSCC) difficult to manage?\",\"answer\":\"HNSCC shows significant genetic heterogeneity and has a low 5-year survival rate. Major contributing factors include HPV (notably type 16), Epstein–Barr virus, tobacco, alcohol use, and poor oral hygiene.\"},{\"question\":\"How does the oral microbiome relate to head and neck cancers?\",\"answer\":\"Differences in oral microbiome profiles have been reported between healthy individuals and patients with head and neck cancers. Certain oral microbes are discussed in the context of altered risk and potential biomarker value.\"},{\"question\":\"Which cancer treatments are reviewed in relation to the microbiome?\",\"answer\":\"The review examines reciprocal effects of treatment and microbiome across radiotherapy, brachytherapy, surgery, immunotherapy, and chemotherapy. It links these modalities to possible microbiome-dependent outcomes and side effects.\"}]","Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain? | PDF",1790013188]